[Retracted] Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer

Figure 6

Immune correlation analysis of CDCA3 in pan-cancer. (a–c) Based on three different algorithms, TIMER, xCell and MCP-counter, the heatmap shows the correlation between CDCA3 expression and immune cell infiltration in pan-cancer. (d) Heatmap showing the correlation results between CDCA3 expression in pan-cancer and immune checkpoints. These immune checkpoints are SIGLEC15, IDO1, CD274, HAVCR2, PDCD1, CTLA4, LAG3, and PDCD1LG2.

(a)

(b)

(c)

(d)